• SENSEX 76,059.77
    -331.62 (--0.43%)
  • BANKNIFTY 56,693.50
    101.50 (+0.18%)
  • HCL Technologies
    1,275.50 1,770.00(%)
  • Shadowfax Technologies
    203.85 98.60(%)
  • Infosys
    1,014.15 984.00(%)
  • Bluestone Jewel
    793.45 872.60(%)
  • Bajaj Finance
    1,002.00 788.40(%)
  • HDFC Bank
    737.20 726.75(%)
  • Caliber Mining
    538.15 538.15(%)
  • E2E Networks
    516.95 516.95(%)
  • Coforge
    1,488.00 1,988.90(%)
  • ICICI Pru Life
    495.55 459.60(%)
  • SBI
    1,018.00 1,234.80(%)
  • AU Small Finance
    1,015.00 1,090.40(%)
  • SRF
    2,697.50 3,257.95(%)
  • Shriram Finance
    992.75 566.40(%)
  • Maruti Suzuki
    13,498.95 17,371.60(%)
  • B H E L
    418.00 446.75(%)
  • CG Power & Ind
    839.25 525.50(%)
  • Interglobe Aviat
    4,886.70 3,894.80(%)
  • Power Grid Corpn
    285.65 250.05(%)
  • Five-Star Bus.Fi
    537.45 733.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3135.0
  • ISIN : INE191A01027
988.60 26 (2.71%)
  • As on 26 Jul 2026 (EOD)

  • Today’s Low

    951.95

  • Today’s High

    999.00

  • Open

    966.00

  • Perv Close

    962.50

  • 52W Low

    480.00

  • 52W High

    1,119.80

Key Indicators

  • P/E(TTM)

    96.76

  • Mar.Cap (₹Cr.)

    5,014.09

  • Div & Yield %

    0.00

  • Book Value(₹)

    270.14

  • Debt-Equity Ratio

    2.71

  • AGM Date

    24-Jul-2026

  • EPS

    10.21

  • P/E Ratio

    96.76

Financials Ratios

  • Debt-Equity Ratio

    0.25

  • Mar.Cap (₹Cr.)

    5,014.09

  • RONW (%)

    3.02

  • ROCE (%)

    3.20

Score Board

  • Equity (₹ in Cr.)

    50.72

  • BV (₹)

    270.10

  • Sales( ₹ in Cr.)

    811.33

  • NP (in Cr.)

    51.78

  • NP Var(%)

    -52.0

  • Div%

    0.0

  • CPS (₹)

    17.20

  • EPS (₹)

    10.20

  • Traded Value (₹ in Lakhs)

    5,010.54

  • 52 Week High

    1,119.80

  • 52 Week Low

    480.00

  • Price BSE

    988.0

  • Price NSE

    989.00

  • Market Capital( in Cr.)

    5,010.54

  • P/C Ratio

    57.40

  • P/E Ratio

    96.80

  • Price Vs.BV

    10.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 921.93 819.37 665.90 556.97 450.70 481.21
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 921.93 819.37 665.90 556.97 450.70 481.21
Other Income 31.93 30.39 58.64 56.97 6.46 24.28
Stock Adjustments 43.85 43.89 21.48 22.73 15.69 20.07
Total Income 997.71 893.65 746.02 636.67 472.85 525.56
EXPENDITURE :            
Raw Materials 588.07 528.35 406.10 336.80 244.96 220.38
Power and Fuel Cost 64.98 62.92 61.26 52.74 39.31 47.44
Employee Cost 86.36 69.64 65.35 60.21 64.40 71.60
Other Manufacturing Expenses 42.32 32.65 29.19 26.26 24.26 40.77
Selling and Administration Expenses 54.76 53.17 34.96 37.77 31.58 58.78
Miscellaneous Expenses 5.36 5.46 7.28 7.22 24.38 112.29
Employee Benefit Expenses 86.36 69.64 65.35 60.21 64.40 71.60
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 841.85 752.20 604.14 521.00 428.89 551.26
Operating Profit 155.85 141.45 141.88 115.67 43.96 -25.71
Interest 14.93 16.71 32.90 33.46 52.21 6.22
Gross Profit 140.92 124.74 108.98 82.21 -8.25 -31.93
Depreciation 34.44 33.22 54.79 87.02 108.90 117.91
Profit Before Tax 106.48 91.52 54.19 -4.81 -117.15 -149.84
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -3.23 0.00 0.00 0.00 0.00
Reported Net Profit 106.48 94.75 54.19 -4.81 -117.15 -149.84
Extraordinary Items -0.32 -0.19 40.00 0.51 0.98 0.09
Adjusted Net Profit 106.80 94.94 14.19 -5.32 -118.13 -149.93
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 88.56
P & L Balance brought forward -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74 -1,953.57
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.70 0.45 0.23 -1.46 -0.60 1.89
P & L Balance carried down -1,882.60 -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 20.99 18.68 13.28 -1.18 -28.70 -36.71
Earnings Per Share(Adj)-Unit Curr 20.99 18.68 13.28 -1.18 -28.70 -
Book Value 247.54 226.69 162.53 149.30 150.13 178.67
Book Value(Adj)-Unit Curr 247.54 226.69 162.53 149.30 150.13 -

Shareholding Pattern

  • Promoter Group

    69.84%

  • Public Share Holding

    30.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,419,957 69.84 35,419,957 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35,419,957 69.84 35,419,957 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32,440 0.06 32,440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 408,009 0.80 408,009 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 2,396 0.00 2,396 1
Insurance Companies 33,877 0.07 33,877 3
Mutual Funds / UTI 10,107,812 19.93 10,107,812 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 347,550 0.69 347,550 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,932,084 21.55 10,932,084 48
2] Non Institution
Bodies Corporate 801,579 1.58 798,341 360
Clearing Members 217 0.00 217 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 228,180 0.45 228,180 611
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 158,650 0.31 158,650 948
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 509,869 1.01 509,869 16
Individuals holding nominal share capital up to Rs. 1 lakh 2,640,879 5.21 2,640,609 31,440
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 26,987 0.05 26,987 2
Others 635 0.00 635 3
Sub Total 4,367,064 8.61 4,363,556 33,384
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,719,105 100.00 50,715,597 33,433

Company Background

Orchid Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Orchid Pharma Ltd
  • BSE Code : 3135.0
  • ISIN : INE191A01027

  • Incorporation Year

    1992

  • Registered Office

    Orchid Towers Nungambakkam
    313 Valluvar Kottam High Road, Chennai,
    Tamil Nadu-600034

  • Telephone

    91-44-28211000/28230000

  • FAX

    91-44-28211002

  • Chairman

    R G Agarwal

  • Managing Director

  • Company Secretary

    Kapil Dayya

  • Auditor

    Singhi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar


    ,
    ,
    Mumbai -

Orchid Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Orchid Pharma 987.90 953.86 921.93 110.88 3.61
Abbott India 28,003.45 7,217.19 6,929.05 38.34 43.78
Astrazeneca Phar 8,000.10 2,304.07 2,275.58 106.65 27.86
P & G Health Ltd 6,723.60 944.52 934.17 34.14 71.75
Glaxosmi. Pharma 2,513.25 3,932.76 3,790.20 42.08 58.17
Cipla 1,410.90 20,102.60 18,979.95 37.08 13.88
Amrutanjan Healt 510.50 469.50 451.82 25.49 21.89
Bliss GVS Pharma 463.55 773.53 729.81 50.77 12.51
Fermenta Biotec. 432.60 474.15 450.25 19.81 18.77
Guj. Themis Bio. 360.50 152.47 150.80 84.23 27.21
Ambalal Sarabhai 32.45 19.52 3.94 22.69 6.77